Clinical Trials Logo

Filter by:
NCT ID: NCT05772494 Recruiting - Sick Leave Clinical Trials

Assessment of Activity Limitations, a Basis for Understanding the Need for Sickness Certificate and Rehabilitation

Start date: April 3, 2023
Phase: N/A
Study type: Interventional

In Sweden mental disorders have the highest proportion of sickness absence and sickness spells. One cause for this is proposed as the lack of knowledge on which activity limitations that have an impact on the ability to return to work. Further, there is a knowledge gap concerning the effect of which early measures from the health system, assessments and early rehabilitation interventions, that enables return to work. Such early measures have been proposed to have a more multidimensional perspective, than to solely focus on specific tasks during a work situation. The aim of the current project is to examine the effect of an early assessment of activity limitations, made by occupational therapists within specialized psychiatric care, at the time for the next prolonged sickness certification. The assessment will be included in the sickness certificate, and results will be compared between the intervention group and a control group. The results are calculated for differences on treatment measures, prevalence of questions from the Social Insurance Agency and changes in the patterns for sick leave spells. Further, the prevalence of activity limitations and the sick listed participants assessments of the effect of the intervention will be presented. The results are expected to lead to more adequate interventions for the individual regarding support to return to work, better routines for assessment and rehabilitation within the health care system, which in turn can facilitate decisions for sickness benefits and further have an impact on the long sick leave spells concerning mental disorders.

NCT ID: NCT05772299 Completed - Clinical trials for Peri-implant Mucositis

Treatment of Inflammation Around Implants With a Laser or an Ultrasonic Device

Start date: August 31, 2021
Phase: N/A
Study type: Interventional

The goal of the clinical trial is to compare laser therapy with ultrasonic therapy in patients with inflammation in the tissue surrounding single implants (peri-implant mucositis). The outcomes are bleeding on probing (BOP), pocket depth, suppuration, recession of the peri-implant mucosal margin, the treatment time and changes in bone levels before and after treatment in the test, and control group respectively. The quality of life will be measured from a standardized protocol. The hypothesis is that treatment with laser therapy in patients with peri-implant mucositis will show less inflammation with less bleeding and a better pocket closure compared to the treatment with the ultrasound.

NCT ID: NCT05768165 Active, not recruiting - Clinical trials for Rheumatoid Arthritis

High-intensity Interval Exercise in Rheumatoid Arthritis

RA-HIIT
Start date: August 16, 2021
Phase: N/A
Study type: Interventional

Cardiovascular performance and overall fitness can be improved by high-intensity aerobic activity, and these benefits may be achievable by persons with rheumatic diseases. The investigators hypothesize that a 12-week high-intensity interval exercise program will provide substantial improvements in cardiovascular function, inflammation and symptoms affecting quality of life.

NCT ID: NCT05767619 Recruiting - Clinical trials for Acute Coronary Syndrome

Digital Decision Support in the Management of Patients With Chest Pain

BRIAN2
Start date: May 15, 2023
Phase:
Study type: Observational

The goal of this observational study is to develop a decision support system in patients presenting with chest pain in the prehospital setting. The main question it aims to answer is: • Performance of a machine learning based model for decision support of patients in contact with emergency medical services due to chest pain Participants will be asked to: - respond to questions asked by the clinician at the scene regarding previous known risk factors and pain characteristics - consent to the collection of routinely available data from medical records - consent of taking one blood sample capillary or venous (if perifer catheter is placed for standard care reasons) troponin and glucose which is measured at the scene, disposed, and the result is entered in the clinical report form.

NCT ID: NCT05767177 Recruiting - Clinical trials for Diabetes Mellitus, Type 2

Jejunal Ketogenesis and Type 2 Diabetes

But2
Start date: June 1, 2023
Phase: N/A
Study type: Interventional

The goal of this cross-over study in obese subjects is to learn about the common co-morbidity type 2 diabetes and the local formation of ketone bodies. The type of study is an exploratory trial with the participants as own controls. The main questions it aims to answer are: 1. Does food intake-induced ketogenesis exist in the small intestine of obese individuals? 2. Are insulin resistance, the incretin GLP-1 release and the glucose transporter SGLT1 affected in obese individuals without type 2 diabetes in the same way as those with type 2 diabetes?

NCT ID: NCT05761067 Recruiting - Clinical trials for Coronary Artery Disease

STICH-3.0 International Trial Consortium

STICH-3
Start date: September 14, 2022
Phase: N/A
Study type: Interventional

The primary objective of the STICH 3.0 Study is to determine whether CABG is superior to PCI in terms of all-cause mortality at 5 years in patients with severe CAD and iLVSD. Individual patient data from similar national RCTs independently powered for different efficacy endpoints will be pooled, harmonized, and analyzed. The primary endpoint is all-cause mortality.

NCT ID: NCT05759663 Not yet recruiting - Muscle Diastasis Clinical Trials

MIRRAD Versus Plication of Entire Diastasis Trial

MIRRADRCT
Start date: August 1, 2024
Phase: N/A
Study type: Interventional

Background Postpartum diastasis of the rectus abdominis muscles (DRAM) has gained increasing attention as a condition that may affect abdominal trunk function but that may be alleviated by surgery. Most techniques for surgical reconstruction of DRAM are, however, associated with high costs, postoperative pain and risk of surgical complications. The aim of the present study is to evaluate a Minimal Incision Repair of Rectus Abdominis Diastasis (MIRRAD) in a randomized controlled open label trial. Altogether 120 women will be included. Population Postpartum women with DRAM of at least 2 cm. Intervention Plication of Linea alba through a 3-5 centimeter long incision at the level of the umbilicus Control Plication of the entire Linea alba through a low transverse incision. Outcome Primary outcome: Abdominal function rated with the Disability Rating Index Secondary outcomes: Operative time, postoperative stay, surgical complications, sick leave, persisting pain orated with the Ventral Pain Hernia Questionnaire, cosmetic outcome rated with BODY-Q Follow-up Follow-up one month and one year after surgery Significance If the study shows that MIRRAD is equally effective as plication of the entire Linea alba one year after surgery, it may be introduced as a standard technique for DRAM. If it is not as effective, it may still be an alternative with advantages in terms of cost benefit and the possibility to perform it as a daycare procedure.

NCT ID: NCT05758987 Recruiting - PTSD Clinical Trials

Blended Treatment för PTSD: A New Format of Computer-Assisted Trauma-Focused Cognitive Behavioral Therapy

Start date: March 10, 2023
Phase: N/A
Study type: Interventional

A Randomized Controlled Non-inferiority Trial testing if the new experimental Blended Trauma focused cognitive behavioral therapy (B-TF-CBT) for post traumatic stress disorder (PTSD), is non-inferior to gold standard control treatment Prolonged Exposure (PE). Research question and hypothesis Can the blended treatment yield outcomes non-inferior to face-to-face TF-CBT for patients with PTSD when applied in regular health care with regards to PTSD-symptoms, depression, anxiety, sleep problems, quality of life and general functioning? The hypothesis is that the Blended TF-CBT will be non-inferior to standard face-to-face TF-CBT for patients with PTSD, directly after treatment as well as at 12-months follow up. The study will be conducted at 3-6 outpatient clinics in Region Stockholm, Sweden.

NCT ID: NCT05757154 Completed - Healthy Clinical Trials

Coffee for Optimal Metabolite Profile

Start date: March 31, 2023
Phase: N/A
Study type: Interventional

The aim of this project is to evaluate metabolite profile after consumption of three types of coffee differing in type of bean, degree of roasting and preparation method. Metabolite profiles will be evaluated after a) a single dose b) 3-day consumption. The study will be carried out as a three-way cross-over design with three different types of coffee. Wash-out periods where participants consume their habitual diet are implemented between all intervention periods. The first day of intervention (single dose) includes postprandial measurements during 13 hours.

NCT ID: NCT05755672 Recruiting - Clinical trials for Metastatic Colorectal Cancer

On-treatment Biomarkers in Metastatic Colorectal Cancer for Life

On-CALL
Start date: March 1, 2023
Phase:
Study type: Observational [Patient Registry]

By virtue of an increased strategic use of cytotoxic and biological agents, and more options for locoregional treatment, the survival of patients with metastatic colorectal cancer (mCRC) has improved considerably in the past decades. The personalized approach to systemic treatment is further aided by the use of complementary molecular biomarkers. However, the evolutionary dynamics of mCRC, a disease harnessed by multiple adaptive genetic alterations towards its final stages, poses a particular challenge to single-sample biomarker analyses and standardized linear treatment protocols. The aim of the On-treatment biomarkers in metastatic ColorectAL cancer for Life (On-CALL) study is to generate further knowledge on the evolutionary progression of mCRC during treatment, and to elucidate the mechanisms underlying the therapeutic failure still seen in a substantial number of patients. The On-CALL study is a prospective, single-arm observational study. All patients diagnosed with synchronous mCRC treated with curative intent at Skåne University Hospital will be invited to participate. Clinical and histopathological data will be compiled at study entry. An individual tissue microarray block with samples from resected primary tumours and metastases representing the full extent of the tumour spread will be constructed for each patient. Blood samples will be drawn for biomarker analyses at multiple time points prior to, during and after systemic treatment. DNA sequencing of tumour tissue and circulating tumour DNA (ctDNA) will be performed to define the spatial clonal landscape in primary tumours and metastases, as well as over time.